Skip to main content
. 2018 Feb 16;15(4):6015–6021. doi: 10.3892/ol.2018.8080

Figure 1.

Figure 1.

Association between the expression of TCONS_00001798 in NSCLC tissues and clinicopathological factors. (A) Relative expression of TCONS_00001798 in NSCLC tissues (n=118) compared with adjacent non-tumor tissues (n=118). TCONS_00001798 expression was detected by reverse transcription quantitative polymerase chain reaction and normalized to GAPDH. TCONS_00001798 expression was significantly lower in patients with (B) advanced pathological stage and (C) lymph node metastasis (N1 or above). (D) TCONS_00001798 expression was not associated with tumor size, measure by diameter. All data are presented as the mean ± standard deviation. NSCLC, non-small cell lung cancer; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; n.s., not significant.